Tecarfarin (sodium)
Tecarfarin sodium (ATI-5923 sodium) is a novel orally active non-competitive vitamin K epoxide reductase (VKOR) antagonist, impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X[1]. Tecarfarin sodium has the antithrombotic activity[2].
Product Specifications
CAS Number
1004551-83-0
Product Name Alternative
ATI-5923 (sodium)
UNSPSC
12352005
Target
VKOR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/tecarfarin-sodium.html
Solubility
10 mM in DMSO
Smiles
O=C1C(CC2=CC=C(C(OC(C(F)(F)F)(C)C(F)(F)F)=O)C=C2)=C(O[Na])C3=C(O1)C=CC=C3
Molecular Formula
C21H13F6NaO5
Molecular Weight
482.31
References & Citations
[1]Hobl EL, et al. Tecarfarin: A Novel Vitamin K Antagonist. Thromb Haemost. 2017 Nov;117 (11) :2009-2011.|[2]Bowersox SS, et al. Antithrombotic activity of the novel oral anticoagulant, Tecarfarin [Sodium 3-[4- ((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in animal models. Thromb Res. 2010 Nov;126 (5) :e383-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4988302 1.0 µg DNA
Sucla2 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
VAng-Lsx2920-1mgEcoli 1 mg (E. coli)
Recombinant Corynebacterium Diphtheriae recF Protein (aa 1-397)
Sign In for Pricing
View Details 
47848111 3x 1.0 µg
TRIM8 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details